Cancer Archives | Newsroom

UNC School of Medicine physician experts Adam Goldstein, MD, MPH (Family Medicine), and Marc Bjurlin, DO, MSc (Urology), are calling for shared decision-making about prostate cancer screening to be built into health care systems, not left to individual clinicians alone. In a new editorial in the Journal of Urology, the authors argue that system-level support is essential to ensure patients can make informed, equitable decisions about PSA screening.

The genetic tool allows doctors to better tailor treatments to each patient's unique subtype of B-cell acute lymphoblastic leukemia.

The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma

The newly developed cells address a significant limitation present in existing treatment approaches and may offer a promising solution for acute myeloid leukemia.

Celebrating its 25th anniversary, the Rex Mobile Mammography, a department of UNC Health Rex Hospital, will welcome a new mobile mammography unit this year named Hope Esperanza, or “Hope.”

A new clinical trial that adjusts treatment as breast cancer evolves is now open and enrolling patients at UNC Lineberger Comprehensive Cancer Center.

The investment will help researchers develop innovative research projects aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.

The prestigious honor recognizes biochemist Jean Cook, PhD, and her work on cancer development and the human cell cycle, a biological process crucial for development, healing, and continued maintenance of the body.

The All-Star Translational Award from the V Foundation will help create new treatments to help patients better fight off pancreatic cancer, one of the most lethal types of cancer.

New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.

Published in Cell Reports Medicine, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy response.

The tool is a one-stop resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.

Category: Cancer

UNC Physician Experts Call for Systems-Based Approach to Prostate Cancer Screening Decisions

UNC Researchers Develop Faster, Low-Cost Method to Diagnose Common Pediatric Cancer

UNC Study Reveals Promising New Therapy for Non-Hodgkin Lymphoma

UNC Researchers Create More Effective, Less Toxic Immunotherapy to Combat Blood Cancer

Traveling with Hope: Rex Mobile Mammography Celebrates 25 Years of Service

A New Clinical Trial for Metastatic Breast Cancer Opens

Two UNC School of Medicine Researchers Receive $1 Million Grants to Advance Innovative Cancer Research

Cook Elected to 2025 AAAS Class of Honorary Fellows

Milner Awarded $1 Million for Pancreatic Cancer Research

UNC Research Shows Natural Compound Could Benefit Lymphoma Patients

UNC researchers develop single sample classifier to predict cancer-associated fibroblast subtypes in patient samples

“Data for Everyone”: A New Cancer Dashboard Launches at UNC Lineberger Comprehensive Cancer Center